GlassScriptPhysician profile
Floriano Marchetti
NPI 1922063882
$4,583.59
in general payments reported to CMS, 2019-2025
14 companies · $22.91 in 2025
The $22.91 reported for 2025 was less than what a typical Colon & Rectal Surgery provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,486 · 2020: $1,578 · 2022: $1,100 · 2023: $212 · 2024: $185 · 2025: $22.91.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $345 · Education: $75.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $344.82 |
| Education | $75.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $1,101.93 | 2020 | |
| Medtronic, INC. | $1,100.00 | 2022 | |
| Covidien LP | $575.00 | 2019 | |
| Intuitive Surgical, INC. | $573.36 | 2019-2024 | Da Vinci Surgical System |
| Innovation Technologies INC | $357.49 | 2020-2024 | Irrisept |
| Thd America, INC. | $277.94 | 2019 | |
| Integra Lifesciences Corporation | $139.29 | 2020 | |
| Ethicon US, LLC | $127.76 | 2019 | |
| Celularity INC. | $109.00 | 2019 | |
| Mallinckrodt Enterprises LLC | $106.85 | 2019 | |
| Conmed Corporation | $57.14 | 2019 | |
| Daiichi Sankyo INC. | $22.91 | 2025 | Enhertu |
| Baudax Bio INC. | $20.56 | 2020 | |
| Novartis Pharmaceuticals Corporation | $14.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Floriano Marchetti listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.